FR2329275A1 - Triazoles substitues - Google Patents
Triazoles substituesInfo
- Publication number
- FR2329275A1 FR2329275A1 FR7632136A FR7632136A FR2329275A1 FR 2329275 A1 FR2329275 A1 FR 2329275A1 FR 7632136 A FR7632136 A FR 7632136A FR 7632136 A FR7632136 A FR 7632136A FR 2329275 A1 FR2329275 A1 FR 2329275A1
- Authority
- FR
- France
- Prior art keywords
- alkyl
- phenyl
- substd
- ring
- halogens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62614075A | 1975-10-28 | 1975-10-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2329275A1 true FR2329275A1 (fr) | 1977-05-27 |
| FR2329275B1 FR2329275B1 (fr) | 1978-12-15 |
Family
ID=24509116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7632136A Granted FR2329275A1 (fr) | 1975-10-28 | 1976-10-25 | Triazoles substitues |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5253863A (fr) |
| AU (1) | AU1881176A (fr) |
| BE (1) | BE847480A (fr) |
| DE (1) | DE2648826A1 (fr) |
| DK (1) | DK478176A (fr) |
| FI (1) | FI763050A (fr) |
| FR (1) | FR2329275A1 (fr) |
| IL (1) | IL50699A0 (fr) |
| LU (1) | LU76062A1 (fr) |
| NL (1) | NL7611944A (fr) |
| NO (1) | NO763569L (fr) |
| SE (1) | SE7611884L (fr) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005000821A1 (fr) * | 2003-06-12 | 2005-01-06 | Eli Lilly And Company | Antagonistes du recepteur tachykinine |
| US7179804B2 (en) | 2002-04-26 | 2007-02-20 | Eli Lilly And Company | Tachykinin receptor antagonists |
| US7320994B2 (en) | 2002-04-26 | 2008-01-22 | Eli Lilly And Company | Triazole derivatives as tachykinin receptor antagonists |
| US9060995B2 (en) | 2012-01-26 | 2015-06-23 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US9730910B2 (en) | 2012-12-18 | 2017-08-15 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
| US11786502B2 (en) | 2013-11-12 | 2023-10-17 | Vanda Pharmaceuticals Inc. | Method of treatment |
| US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI834666A (fi) * | 1982-12-23 | 1984-06-24 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya aralkyltriazolfoereningar. |
| US4801594A (en) * | 1984-06-18 | 1989-01-31 | Eli Lilly And Company | Aromatase inhibitors |
| CA2015267A1 (fr) * | 1989-05-26 | 1990-11-26 | Rainer Seele | 8-azolylmethylquinolines |
| MX2017009824A (es) | 2015-01-30 | 2017-11-02 | Neurocrine Biosciences Inc | Triazoles sustituidos y metodos relacionados a estos. |
| US9771335B2 (en) * | 2015-07-31 | 2017-09-26 | The Johns Hopkins University | Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels |
| CN105801499A (zh) * | 2016-04-15 | 2016-07-27 | 华东理工大学 | 烯酮制备新型有机oled试剂的设计及其应用 |
| CN111196785B (zh) * | 2020-01-21 | 2021-08-31 | 成都新朝阳作物科学股份有限公司 | 三氮唑衍生物及其制备方法和用途 |
-
1976
- 1976-10-18 IL IL50699A patent/IL50699A0/xx unknown
- 1976-10-19 AU AU18811/76A patent/AU1881176A/en not_active Expired
- 1976-10-19 NO NO763569A patent/NO763569L/no unknown
- 1976-10-20 BE BE171671A patent/BE847480A/fr unknown
- 1976-10-22 DK DK478176A patent/DK478176A/da unknown
- 1976-10-25 JP JP51128163A patent/JPS5253863A/ja active Pending
- 1976-10-25 LU LU76062A patent/LU76062A1/xx unknown
- 1976-10-25 FR FR7632136A patent/FR2329275A1/fr active Granted
- 1976-10-26 SE SE7611884A patent/SE7611884L/xx not_active Application Discontinuation
- 1976-10-26 FI FI763050A patent/FI763050A/fi not_active Application Discontinuation
- 1976-10-27 DE DE19762648826 patent/DE2648826A1/de active Pending
- 1976-10-28 NL NL7611944A patent/NL7611944A/xx not_active Application Discontinuation
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179804B2 (en) | 2002-04-26 | 2007-02-20 | Eli Lilly And Company | Tachykinin receptor antagonists |
| US7320994B2 (en) | 2002-04-26 | 2008-01-22 | Eli Lilly And Company | Triazole derivatives as tachykinin receptor antagonists |
| WO2005000821A1 (fr) * | 2003-06-12 | 2005-01-06 | Eli Lilly And Company | Antagonistes du recepteur tachykinine |
| US10610510B2 (en) | 2012-01-26 | 2020-04-07 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US11826339B2 (en) | 2012-01-26 | 2023-11-28 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US9549913B2 (en) | 2012-01-26 | 2017-01-24 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US9855241B2 (en) | 2012-01-26 | 2018-01-02 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US10149829B2 (en) | 2012-01-26 | 2018-12-11 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US10449176B2 (en) | 2012-01-26 | 2019-10-22 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US9060995B2 (en) | 2012-01-26 | 2015-06-23 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US10945988B2 (en) | 2012-01-26 | 2021-03-16 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US11918556B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US11285129B2 (en) | 2012-01-26 | 2022-03-29 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US11633377B2 (en) | 2012-01-26 | 2023-04-25 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US11850229B2 (en) | 2012-01-26 | 2023-12-26 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US9539234B2 (en) | 2012-01-26 | 2017-01-10 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US11833130B2 (en) | 2012-01-26 | 2023-12-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US9730910B2 (en) | 2012-12-18 | 2017-08-15 | Vanda Pharmaceuticals, Inc. | Treatment of circadian rhythm disorders |
| US11786502B2 (en) | 2013-11-12 | 2023-10-17 | Vanda Pharmaceuticals Inc. | Method of treatment |
| US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1881176A (en) | 1978-04-27 |
| JPS5253863A (en) | 1977-04-30 |
| SE7611884L (sv) | 1977-04-29 |
| BE847480A (fr) | 1977-04-20 |
| LU76062A1 (fr) | 1977-05-18 |
| FI763050A (fr) | 1977-04-29 |
| IL50699A0 (en) | 1976-12-31 |
| DE2648826A1 (de) | 1977-05-05 |
| FR2329275B1 (fr) | 1978-12-15 |
| NL7611944A (nl) | 1977-05-02 |
| DK478176A (da) | 1977-04-29 |
| NO763569L (fr) | 1977-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2329275A1 (fr) | Triazoles substitues | |
| DK177585D0 (da) | Pyridazinoner | |
| ES430584A1 (es) | Procedimiento para la preparacion de nuevas indolil-pipe- ridino- (o 1,2,5,6-tetrahidro-piridil)-butirofenonas. | |
| ES8204421A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acido 1-(ciclohexil)-4-aril--4-piperidincarboxilico. | |
| ES8305344A1 (es) | Un procedimiento para la produccion de un derivado de piperazina. | |
| AU3582289A (en) | Butenoic or propenoic acid derivative | |
| IL97607A0 (en) | Retinoids,their manufacture and pharmaceutical compositions containing them | |
| GB937732A (en) | New aminopyrazoles and their use | |
| PT78566A (de) | Pyridazinone ihre herstellung und verwendung pyridazinone enthaltende arzneimittel | |
| TW372964B (en) | Substituted 2-phenylpyridines, compositions containing same, processes for preparing same and their uses | |
| AP8800109A0 (en) | "Heterocyclic insecticides". | |
| DK0607163T3 (da) | Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner | |
| ES335097A1 (es) | Procedimiento para la obtencion de un herbicida. | |
| GB1482736A (en) | 1-(beta-d-ribofuranosyl)-1,2,4-triazole acid derivatives | |
| ES424436A1 (es) | Procedimiento para la preparacion de 1-(1-unidayolprocedimiento para la preparacion de 1-(1-imidazolil)- iso- quinoleinas. il)-iso- quinoleinas. | |
| GB1224720A (en) | Production of benzodiazepines | |
| NO932002L (no) | Nye tiosemikarbazonsyreestere | |
| FR2085645A1 (en) | 1-phenyl-2,3-benzodiazepin-4-ones - as tranquillizers | |
| ES449530A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piridona. | |
| FR2021123A1 (fr) | Nouveaux derives du 1,3-diamino-propane-2-ol | |
| GB1410925A (en) | Pharmaceutical compositions containing 1-phenyl biguanides and a process for their production | |
| SE7906433L (sv) | Pyrazolylaminoimidazoliner | |
| MY102050A (en) | Imidazole anologs of mevalonolactone and derivatives thereof | |
| ES335264A1 (es) | Procedimiento para la obtencion de un herbicida. | |
| ES2019242A6 (es) | Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |